Recursion Pharmaceuticals, Inc. (RXRX)

Recursion Pharmaceuticals Revenue

In the year 2025, Recursion Pharmaceuticals had annual revenue of $74.68M with 26.92% growth. Recursion Pharmaceuticals had revenue of $35.54M in the quarter ending December 31, 2025, with 681.74% growth.

• Revenue (ttm): $74.68M
• Revenue Growth: +26.92%
• P/S Ratio: 22.00
• Revenue / Employee: $124,468
• Employees: 600
• Market Cap: 1.64B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	74.68M	15.84M	26.92%
Dec 31, 2024	58.84M	14.26M	32.00%
Dec 31, 2023	44.58M	4.73M	11.88%
Dec 31, 2022	39.84M	29.67M	291.46%
Dec 31, 2021	10.18M	6.22M	156.89%
Dec 31, 2020	3.96M	1.64M	70.85%
Dec 31, 2019	2.32M	-	-